Log In
Print this Print this

Ragweed-SPIRE, ToleroMune Ragweed

  Manage Alerts
Collapse Summary General Information
Company Circassia Pharmaceuticals plc
DescriptionSynthetic allergen-derived peptide desensitizing vaccine against ragweed that uses ToleroMune T cell epitope desensitization technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationAllergy
Indication DetailsTreat ragweed allergy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today